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Abstract
Malarial systemic pathophysiology refers to physiological changes or abnor-
malities that are experienced by individuals infected with the Plasmodium para-
site not be presenting in the absence of active, chronic or previous infection. The 
pathologies are derived, in part, from OS induced insults whose mediators are 
readily available in malaria. The malaria disease is equivalent to the pathophysi-
ology as shown by the abnormal syndromic expressions ranging from ailments 
that affect homeostatic mechanisms and processes to tissues and organ specific 
damages and derangements. Phytotherapeutic remedies refer to the natural 
phytochemicals or plant medicinal compounds and their derivatives with known 
antiparasitic and antimalarial disease effects in both experimental and clinical 
situations. The chapter explores how Plasmodium infection generates or cause 
to be generated oxidative stress, how oxidative stress drives systemic disease 
process and how phytotherapeutics treatment (artemisinins) and administration 
(asiatic acid) in malaria resolves the various pathologies as a current situational 
analysis.
Keywords: malaria, phytochemicals, phytotherapeutics, asiatic acid, artemisinin, 
severe malaria anemia, Plasmodium falciparum, oxidative stress, reactive oxygen species, 
anti-disease
1. Introduction
Inferences into free radicals’ release and their subsequent OS generation has 
been described as the causes and drivers of malaria [1–3]. The Plasmodium [4]-free 
radical production [5]-antioxidant defense systems [6] triumvirate axis may be 
elaborate in the host cell as a pathologic apparatus triggered to subside malarial 
infection intensity. The character of OS has scarcer shades of clarity up to date 
with some authors insinuating a protective facilitation against malaria disease, 
others claim a pathophysiologic role in the pathogenesis of the disease [6]. Studies, 
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however, tend to associate the production of reactive oxygen (ROS) and nitrog-
enous species (RNS) with OS (OS) in the development of complex sequalae and 
systemic malarial disease and its outcomes.
Malarial parasite infection invokes hydroxyl free radical (OH˙) production by 
the hepatocytes which may induce OS and apoptosis of liver parenchymal cells [7]. 
Additionally, it has been observed that parasitized red blood cells (pRBCs) generate 
OH˙ radicals and H2O2 at approximately double the concentration found in non-
parasitized red blood cells (npRBCs); an elicitation from the abundant intracell and 
endogenous redox reaction players.
Free hemoglobin (Hb), copiously available in malaria, is also a readily obtain-
able foundation of free radicals as the Plasmodium parasite uses the Fe2+-containing 
molecule as a fountain of amino acids crucial for its sustenance during the erythro-
cytic stage of disease. The main component and source of protein-bound and free 
Fe2+ is high levels of haeme. The haeme-Fe2+ complex induces intravascular OS with 
deleterious conformational changes to the red blood cells (RBC’s) and the endothe-
lial cells. Consequentially, release from pRBC’s during haemolysis and subsequent 
internalization of malarial parasites into liver and brain tissues ensues with varied 
malarial syndromes presentations [8].
Generally, free haem release during cell haemolysis has a prospective capacity of 
increasing OS through the Fenton-Fritz Haber-Joseph Joshua Weiss reaction [9, 10] 
which iron catalyzes, mainly: Fe3+ + ˙O2
− → Fe2+ + O2.





And OS created by excess hydroxyl radicals (˙OH), superoxide (O2˙
−), reactive 
non-radical compounds including singlet oxygen (1O2), hydrogen peroxide (H2O2), 
lipid hydroperoxides, hypochlorous acid (HOCl), chloramines (RNHCl), and ozone 
(O3) [11, 12] potentiates malarial infection patency and snowballing risk for fulmi-
nant disease. In the non-immune individuals, cell-mediated immune response is the 
initial defense mechanism which generates OS as well and subsequently, aberrant 
immune system response with disease traction increases.
Reactive nitrogen radical compounds such as nitric oxide (˙NO), nitrogen 
dioxide (˙NO2), and non-radical nitrogen-based compounds which include per-
oxynitrite (ONOO−) and dinitrogen trioxide (N2O3), make up the collective group 
of reactive nitrogen species (RNS). The unpaired electrons in their outer electron 
obit make these species very unstable and highly reactive. Reactive nitrogen species 
have direct linkages to ROS, especially in the formation of ONOO− which gives rise 
to nitrosative stress (NS).
The combination of OS and NS have been associated with the etiology of an 
extensive variety of disease processes and states to include aging, infections, 
ischemia-reperfusion (I/R) injury [13], acute kidney injury (AKI) and chronic 
kidney diseases [14], diabetic neuropathies [15], inflammatory disease [16], vascu-
lar dysfunction and hypertension [17], atherosclerosis, neurological diseases [18] 
including Alzheimer’s disease [19, 20]. Most of these conditions and diseases are 
displayed as syndromes and facets of malaria disease.
Management of malaria, will of necessity therefore, require the inclusion of 
anti-disease remedies that will concurrently suppress or eradicate the pathophysiol-
ogy associated with malarial. There have been strides to invent remedial treatment 
for malaria by improving the potency of current antimalarials. However, this 
avenue does not correspond to requirement of ameliorating the disease aspect of 
malaria. Phytochemicals, some in basic research stage of investigation or clinical 
stages, show promising outcomes that are worth promulgating, formulating and 
pre-empting strides towards attempts to eradicate both the parasite and the sequa-
lae of malaria.
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1.1 Malaria causes
There are five main Phylum Apicomplexa (Sporozoa) Plasmodium strains 
inflicting human malarial infection with changing disease outcomes, mainly 
P. falciparum, P. vivax, P. malariae, P. ovale and a zoonotic parasite P. knowlesi. 
Accordingly, parasite species, sub-species, host genetics and host demographics 
at point of infection, determine malaria disease presentations of varying intensi-
ties [21]. A disease process and time-lines with differing syndromic mediators is 
generated [22, 23]. The P. falciparum infection has the highest fatalities with strains 
having developed multidrug resistance. Artemisinin derivatives are the latest 
additions to the rug-casualties list. P. vivax and P. ovale present chronic disease 
with quiescent liver stage parasite hypnozoites driving disease relapses onwards of 
7 years duration from initial infection reported [24]. However, there is divergent 
of opinion straying from this recrudescence dogma [25].
1.2 Phenotypic presentations of malaria
Malaria disease displays manifestations in adults from non-endemic areas as a 
different disease phenotype when compared to pregnant women and to children 
under the age of 5-years. Accordingly, the pathophysiology of malaria, or malaria 
disease [26] displays immunological idiosyncrasies, inflammatory aberrations, 
haemolysis which may lead to severe malaria anemia (SMA) [27], acute kidney 
injury (AKI) [28], and malaria cachexia leading to cardiac failure [29], hypoglycae-
mia [30, 31], acute respiratory distress syndrome (ARDS) [32], acute lung injury 
(ALI) [33], cerebral malaria [34], hyperlactaemia with non-respiratory acidosis. Of 
these pathophysiology, children invariably develop SMA [35], hypoglycaemia [36], 
hyperlactaemia with non-respiratory acidosis and cerebral malaria while adults 
presents with severe malaria, AKI [37] and non-respiratory acidosis [38]. Pregnant 
women present with placental malaria with SMA also a common feature [39]. The 
bottom line to all these manifestations is the OS mediation to the disease process 
driven by various species emanating from the parasite-human host interactions. 
The perceived relationship between the antioxidant capacities displayed by phyto-
chemicals and phytotherapeutics and the oxidant-driven malaria disease motivates 
this chapter.
2. Malarial systemic disease and phytochemicals administration
The terms phytotherapeutics, phytotherapeutics are commonly used in the 
branch of science involved in the use of plant natural products and their derivatives 
and their use as disease management alternatives and ameliorates. The discovery 
that phytochemicals like the artemisinin, asiatic acid (AA), oleanolic acid and 
masilinic acid (MA) have both anti-inflammatory (and other physiological influ-
ences) activity and antimalarial activities have led to the exploration of their 
anti-disease action in malaria.
3. Oxidative stress and artemisinin malarial treatment
Artemisinin is a tetracyclic 1,2,4-trioxane containing an endoperoxide bridge 
(C─O─O─C), the key pharmacophore of the antimalarial [40] (Figure 1). 
Increasing solubility and pharmacological of the drug has been achieved when 
semi-synthetic compounds were synthesized through modification of C10 in the 
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original backbone to generate hemi-acetal or ester derivative such as dihydroarte-
misinin (Figure 2), artemether (Figure 3) and artesunate (Figure 4) [41].
The debate remains unresolved on the mode(s) of activation and consequent 
biological target(s) of endoperoxides [43]. Activation of the endoperoxide bridge 
is believed to be the source of artemisinin antimalarial activity. Cleavage of the 
bridge, which is located at the core of the structure, generates short-lived cytotoxic 
oxyradicals in the presence of haem iron or free iron Fe2+ [44, 45]. However, two 
different mechanisms of action premised on the endoperoxide bioactivation, have 
been proposed.
Rearrangement of the oxygen-centred radicals, to produce more stable carbon-
centred radicals, have been hypothesized by the Poster Laboratory using 18O-labeled 
trioxane analogues [46, 47]. The ‘reductive scission’ model, has ferrous iron bind-
ing to either O1 or O2 cleaving the endoperoxide bond and generating oxyradical 
intermediates which subsequently rearrange to primary or secondary carbon-centred 
radicals via either b-scission or a [1,5]-H shift. This hypothesis has been supported 
through evidence of the formation of these carbon-centred radical intermedi-
ates using electron paramagnetic resonance spin-trapping techniques [48, 49]. 
Figure 1. 
Artemisinin, structure of the endoperoxides [42].
Figure 2. 
Dihydroartemisinin, structure of the endoperoxides [42].
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Capabilities of the C-centred radicals to drive haem and or proteins alkylation have 
been proposed. However, the only evidence, so far provided, has been for haem 
alkylation [50] and a few reported model studies on protein alkylation with ferrous 
salts reactions in the presence of cysteine (iron-sulfur chelates) [51].
The concept of free radical generation and protein alkylation points towards 
creation of OS as the parasite killing apparatus of the artemisinin derivatives but also 
indicates the deleterious effect of the drugs on the human host and possibility of ini-
tiating or exacerbating malarial disease in the course antiparasitic activity. However, 
paradoxically artemisinin has been reported to be pluripotent with anti-inflammatory 
activity [52] although post treatment artemisinin haemolysis has also been observed 
in people that would have been cleared of malaria. The latter adverse reaction has 
been seen several weeks after successful treatment with artemisinin drugs.
3.1 Artemisinin and anti-oxidative stress disease inductions
Artemisinin and its derivatives require conversion to the biologically active 
dihydroartemisinin (DHA Figure 2) to exert their activity. Besides the excellent 
antimalarial effects, there is clinical and experimental evidence that suggests potent 
Figure 3. 
Artemether, structure of the endoperoxides [42].
Figure 4. 
Artesunate, structure of the endoperoxides [42].
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immune-suppressive against autoimmune and allergic disease of artemisinin and its 
derivatives [52]. Derivatives of artemisinin possessing lower range toxicity, higher 
bioavailability, and compelling immunosuppressive activity have been studied and 
some commercialized. These are 3-(12-𝛽-artemisininoxy) phenoxyl succinic acid 
(SM735) [53], 1-(12-𝛽-dihydroartemisinoxy)-2-hydroxy-3-tert-butylaminopropane 
maleate (SM905) [54, 55], ethyl 2-[4-(12-𝛽-artemisininoxy)] phenoxylpropionate 
(SM933) [56], and 2′-aminoarteether (𝛽)maleate (SM934) [57, 58].
To date, it is generally accepted that artemisinin wields antimalarial proper-
ties through (i) haeme or free iron breaking the peroxide bridge resulting in the 
degradation of artemisinin molecular structure to form the nucleophilic radical 
metabolite with the centre at C4. (ii) subsequently, the free radical, acting as 
an alkylating agent, will attack macromolecular bearing electrophilic groups or 
centres, which ultimately leads to parasitic demise [50, 59]. In fact, the pRBC’s have 
increased concentrations of OS due to the parasitic infection by Plasmodium. In the 
intervening time, OS driven free radicals and lipid peroxidation concentrations 
dramatically increase intracellularly. Apparently, pRBC’s are rendered more suscep-
tible to artemisinin than npRBC’s. In vivo artemisinin is effective in killing pRBC’s 
at nM concentrations which differs sharply when contrasted to marginal effects of 
artemisinin on resting RBC’s even at high mM concentrations [60, 61].
3.2 Anti-inflammation and immunoregulatory effect of artemisinin
There are three fundamental steps by which T cells perform pivotal role in 
acquired immune reaction [62, 63]: (i) G0 to G1 transition of T cells is driven by 
TCR cross-linking which leads to the secretion of T cell growth factor IL-2 and 
expression of high-affinity receptor IL-2R𝛼 chain (CD25); (ii) through autocrine 
and or paracrine proliferative loop, IL-2 influences clone expansion and maintains 
activated T cells survival; (iii) after efficacious clearance of the pathogen, the 
inducement for cytokines production is lost and activated T cells will undergo 
apoptosis.
Nevertheless, in autoimmune diseases, due to the tenacity of autoantigen, auto-
reactive T cells will be activated and with better survival [52]. Autoreactive T cell 
proliferation is involved in the pathogenesis of various immune-related diseases, 
such as rheumatoid arthritis (RA) and multiple sclerosis (MS) [20, 21] as well as 
malaria.
Artemether is a powerful antimalarial drug [64] found to significantly suppress 
the proliferation and synthesis of IL-2 and interferon-𝛾 (IFN-𝛾) by T cells through 
the TCR engagement influence [65]. The TCR engagement-triggered MAPKs signal-
ing pathway as well as phosphorylation of ERK1/2, Jnk, and P38 were significantly 
inhibited by artemether. Discovery was made that artemether greatly affects T cells 
function as compared to that of the antigen presenting cells (APCs) to exert the 
immunosuppressive effects [65].
A series of artemisinin derivatives, with higher water solubility and lower 
toxicity, have been created by inserting, to the parent artemisinin structure, new 
functional groups like ethylene glycol [66, 67]. These have immunosuppressive 
targeted at T cell activation suppression, combat inflammation through substantial 
inhibition of the proliferation and production of IFN-𝛾, IL-12 and IL-6. While there 
is no direct influence of artemether and its derivatives on IL-2 and CD25 upregula-
tion of T cells, there is remarkable suppression of IL-2-mediated proliferation and 
survival of activated T cells alluding to blocking of IL-2 induced phosphorylation 
of Akt [68]. Additionally, artemether derivative SM934-driven preferential early 
apoptosis activated of T cells, with no effect on resting T cells, has been observed 
through staining of CD69 and annexin V.
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Furthermore, studies suggesting that artemisinin derivatives bind to calmodulin 
to inhibit phosphodiesterase activity, which causes the increase of intracellular 
cAMP concentration, and therefore to exert the immunosuppressive activity have 
been reported [69, 70].
Additionally, oral treatment of SM905 has been shown to skew the T cell subset 
from pathogenic Th17 to protective Th2 subset in an arthritic model with increased 
IL-4 production and suppression of the ROR𝛾t mRNA expression together with 
IL-17 production [71]. The artemisinin derivatives’ effects hinge on the anti-
inflammatory properties which play an antimalarial role. To back this assertion up, 
artesunate has minor effects on inflammatory responses downstream of antibody 
production demonstrating that highly proliferative germinal centre B cells are the 
most sensitive cellular targets to the treatment. Significantly, in vitro artesunate 
inhibits IL-1𝛽, IL-6, and IL-8 production by way of stimulation by TNF-α as well 
as the expression of vascular endothelial growth factor and hypoxia-inducible 
factor-1𝛼 [72]. Moreover, artesunate inhibits Akt phosphorylation and I𝜅B degrada-
tion by blocking PI3K/Akt signaling pathway downstream of TNF-𝛼 [73] making it 
an efficient adjunct to malarial inflammatory response characterized by increased 
and decreased Th1 and Th2 type cytokines, respectively.
The intriguing anti-inflammatory properties of the artemisinin (SM933) are 
observed through the regulatory mechanism involving the NFKB and Rig-G/JAB1 
pathways which regulation alters cell cycle activity of activated T cells selectively. In 
contrast to SM933, SM934 and DHA treatment is majorly through the regulation of 
the balance between effector T cells and regulatory T cells. Administering of DHA 
significantly decreases effectors CD4 T cells and increases in Treg cells in a recipro-
cal regulatory process through modulation of the mTOR pathway which character-
izes its regulatory mechanism [56, 74].
3.3 Artemisinin structure: activity relationship in oxidative stress
Macromolecules bearing electrophilic groups or centres are prone to alkylat-
ing nucleophilic radicals, metabolites of artemisinin, which eventually leads to 
cell damages [61]. Furthermore, artemisinin inhibits endoplasmic reticulum Ca2+ 
ATPase (SERCA) with consequent cytoplasmic calcium accumulation and second-
ary activation of cellular calcium influx. In this way artemisinin induces  
P. falciparum cellular apoptosis [75]. The same effect has been shown by thapsigargin 
(TG), a specific SERCA inhibitor with structural similarity to artemisinin, which 
induces cellular calcium accumulation leading to apoptosis. While artemisinin and 
TG have the same binding sites on SERCA, there are structural biology differences 
in the binding pocket for different mammalian and Plasmodium species resultantly 
conferring differential susceptibility to the drug. A single amino acid (Leu263) 
in the transmembrane segment 3 of SERCA in P. vivax SERCA (PvCERCA) has a 
3-fold sensitivity to artemisinin while introduction of the same residue in P. berghei 
SERCA (PbSERCA) decreases sensitivity 3-fold [75, 76].
Interestingly, while the peroxide bridge plays a necessary role in the artemis-
inin biological activity, artemisinin-SERCA binding does not involve this moiety 
[77] but play a catalytic role in the inhibition [52]. Naturally, stereochemistry 
and transitional state theory have it that the intact peroxide bridge makes the 
spatial configuration of artemisinin to be relatively rigid and making the sesqui-
terpene lactone unable to flexibly rotate and fold. This results in lower affinity for 
SERCA. Reduction and breaking of the peroxide bridge by divalent iron ion, how-
ever, releases the sesquiterpene lactone increasing its flexibility and binding affinity 
to SERCA enhancing inhibitory effect of artemisinin on the enzyme. Moreover, the 
concentration of Fe2+ in pRBC’s and activated lymphocytes is significantly increased 
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compared to resting state cells increasing the opportunity for peroxide bridge to be 
broken. In this manner, the pRBC’s and activated leukocytes, rather than npRBC’s 
and resting cells, become more vulnerable to artemisinin activity. Nevertheless, the 
mammalian SERCA is not susceptible to artemisinin inhibition [75]. Therefore, the 
biochemical mechanism and artemisinin molecular target to exert immunosup-
pression in malaria and other disease driven by OS requires further perusal and 
investigations.
4.  Asiatic acid (AA) administration and oxidative stress-driven 
malarial disease
Asiatic acid (AA), in Figure 2, is a naturally occurring pentacyclic triterpenoid 
originating from the herb Centella asiatica. Triterpenoid saponins are the primary 
constituents of C. asiatica responsible for extensive therapeutic actions. The 
molecular mechanisms underlying the various biological activities of AA have 
been described for malarial diseases as it is driven by OS. The pharmacological 
properties of AA and its derivatives inhibit multiple pathways of intracellular 
signaling molecules and transcription factors that are involved in the various 
stages of acute and chronic diseases [78]. The anti-inflammatory [79], anti-
hyperlipidemia, malarial hypoglycaemia ameliorative effective [30], neuroprotec-
tive, reno-protective effects [80] and other activities of AA have an intricate and 
elaborate pattern, amongst the triterpenes, that is envisaged on the pleiotropic 
characteristics bed rocked on its anti-oxidative pro-oxidative properties and redox 
reactivity [81, 82].
4.1 Severe malaria anemia (SMA) and anti-disease effects of asiatic acid activity
One of the major causes of morbidity and mortality in malaria is SMA driven by 
a multifaceted etiology. Noteworthy mechanisms contributing to SMA include  
(i) increased destruction of pRBC’s and npRBC’s (immune system mediated hae-
molysis, phagocytosis, splenic sequestration); (ii) decreased RBC’s synthesis from 
immune system and parasite effects [83, 84]. The number of RBC’s turnover is a bal-
anced process under normal physiology and a decrease in concentration (anemia) 
is predicted by an efflux of reticulocytes from hematopoietic tissues. When anemia 
develops from increased RBC’s destruction, such as haemolysis or hemorrhage, 
erythropoietin (EPO) production in kidneys is normally up-regulated with a con-
comitant increase in reticulocytosis to alleviate rheological disturbances. Together 
with EPO, growth factors and cytokines, to include granulocyte colony-stimulating 
factor (G-SF), stem cell factor (SF), insulin-like growth fator-1 (IGF-1), take active 
involvement in erythropoiesis [85, 86].
Therefore, production of EPO in the peritubular fibroblasts of the renal cortex, 
requires that the kidneys physiology be normal [87, 88] and is determined by the 
amount of oxygen present which depends on the concentration of RBC’s. Tissue 
oxygen tension and hypoxia regulates EPO production in a feed-back loop with 
hematocrit, centred on an inverse logarithmic relationship [89]. Increased hypoxia 
resulting from SMA causes increased OS. Therefore, antioxidant capacity of AA is 
able to correct hematocrit and ameliorating SMA [26]. However, the principle by 
which this effect of AA on OS in SMA is premised on its effect in reducing kidney 
lipid peroxidation and increasing antioxidant defenses in malaria.
This has a positive effect on oxygen tension and EPO production [90]. Overall, 
OS driven by SMA revolves around hypoxia which emanates from reduced oxygen 
delivery due to reduced RBC’s mass exacerbated by dysfunctional EPO synthesis. 
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Correction of both OS and SMA, as does AA, is pivotal to malarial disease ameliora-
tion and resolution through modulation of the immune system responses.
4.2 Immune system as mediator of SMA generation
While the immune system plays a fundamental part in erythropoiesis, in SMA, 
the immune response is central to its pathogenesis with pRBC’s, hemozoin, and 
glycosylphosphatidylinositol (GPI) which activates monocyte and lymphocyte 
singly or jointly followed by increased inflammatory mediator synthesis. Pro-
inflammatory mediators TNF-α, TNF-γ, IL-1 and IL-23 tend to be up-regulated 
while anti-inflammatory cytokines IL-4 and IL-10 exhibit low concentrations in 
SMA [91, 92]. The over expression of Th1 cytokines in malaria and SMA invari-
ably affects erythropoiesis negatively and enhance OS. There is a close association 
between macrophage inhibiting factor (MIF) and SMA with bone marrow (BM) 
activity suppression influenced by NO as a powerful erythropoiesis inhibitor [93, 94].  
Haemolysis and associated Plasmodium products like hemozoin intrinsically moti-
vates SMA, erythropoiesis dysfunction, vasoconstriction which perturbs inducible 
nitric oxide synthase (iNOS) and increased EPO compensatory increases. However, 
increased EPO concentrations convoyed by insufficient erythroid progenitors 
response results in low reticulocytotic presentations [92, 95]. Ultimately, ineffective 
erythropoiesis, erythrophagocytosis and iron delocalisation may have a bearing on 
SMA [96]. Taken together, inflammatory responses and OS, which are corrected by 
AA administration, have a strong bearing in SMA outcomes.
Transdermal delivery of AA, as a once off application of a pectin hydrogel 
patch, influences hematocrit (Hct), a surrogate marker for SMA, suggests the 
phytochemical has influence on some yet unidentified mechanism of red blood 
cell (RBC) molecular level metabolism [79]. By influencing the causes of low Hct 
and SMA, which could be increased parasitaemia induced-haemolysis or inflam-
mation induced-erythropoiesis-suppression, AA is able to address reduced RBC’s 
concentration of malaria. Inflammation drives OS (and vice versa) and its attending 
outcomes through well-established mechanisms involving cytokines and other 
soluble effector molecules in a vicious cycle.
The TNF-α and other cytokines are well established inflammatory mediators. 
Reports of AA inhibition of TNF-α in acute pancreatitis in corneal lipoploysaccha-
ride induced inflammation have been made. The phytochemical’s antinociceptive 
activities and anti-inflammation in mice has been linked to its ability to inhibit 
cytokine activity [97–99]. Ultrasensitive fourth generation CRP concentrations 
have been shown to be significantly lower in P. berghei (murine malaria)-infected 
rats administered with both oral and transdermal amidated hydrogel matrix pectin 
patch as compared to untreated animals. This indicates an anti-inflammatory 
effect of the phytochemical [79] which is an essential anti-disease effect in malaria 
through inhibition of inflammatory markers like TNF-α.
Nonetheless, it has been shown that TNF-α causes hypoferraemia and reduces 
intestinal absorption of iron [100, 101]. A strong influence of SMA generation 
has been shown by increased concentrations of the cytokine in malaria [102] with 
a distinct mechanism for inadequate erythropoiesis linked to the cytokine [103]. 
Inflammation is a crucial driver of malaria where TNF-α is a key component, and 
SMA is a common complication [104] through erythropoiesis perturbations [105]. 
Therefore, it stands to reason that AA’s influence on both inflammation and SMA 
could be through inhibition of TNF-α as an association between suppression of the 
cytokine by the phytochemical has been observed.
As a result, the relationship between AA and TNF-α in malaria present 
key proponents to malaria disease management. Notwithstanding, a similarly 
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structured triterpene, oleanolic acid (OA), has been reported to attenuate pro-
inflammatory cytokines (TNF-α and IL-6) release and ameliorate anemia in murine 
malaria [106], properties that AA has been reported to have in other inflammatory 
 conditions [107].
Ferroportin (FPN), an abundant protein in the reticuloendothelial system which 
mediates iron release and intestinal iron absorption, has its cytoplasm re-localisa-
tion induced by TNF-α [108]. This effect is obtained through working in tandem 
with hepcidin which is abundantly expressed in malaria and other chronic diseases 
with concomitant EPO resistance and dyserythropoiesis [109, 110]. Thus, possible 
inhibition of TNF-α and the known amelioration of anemia in malaria by AA may 
positively influence TNF-α-induced hypoferraemia which is driven by inflamma-
tory mediators on hepcidin [101].
4.3 Ferroportin (FPN) and SMA
Interestingly, FPN expression on RBC’s (54,000 copies per cell) has been 
reported as a novel finding for a protein that had not been thought to be found on 
these cells as export of Fe2+ had been thought to occur only after haemolysis of 
pRBC’s [111]. By the exportation of iron generated by hemoglobin autoxidation, 
FPN protects against iron accumulation, as well as malaria infection and haemolysis 
creating an antioxidation status in the cell. In situations where there is increased 
inflammation, increases hepcidin synthesis which dysregulates FPN metabolism 
and increases Fe2+ accumulation within both the pRBC’s and npRBC’s promotes iron 
deficiency and haemolysis from OS [112]. The ability of AA to ameliorate malaria-
associated inflammation and OS is critical in to the phytochemical’s salvaging of 
Hct and SMA through preservation and or upregulation of FPN activity in both 
pRBC’s and npRBC’s. By reducing cellular Fe2+ in pRBC’s parasites proliferation 
intracellularly is inhibited and protection against the disease conferred. Iron 
supplementation in malaria down-regulates FPN influencing growth of the parasite 
worsening malaria [113, 114]. Upregulation of FPN by AA is a possible mechanism 
by which the phytotherapeutic effects antiparasitic activity and anti-disease in 
murine malaria.
4.4 The inflammasome in chronic disease and asiatic acid administration
The inflammasome, a key component in the development of chronic disease 
anemia is characterized by anemia and decrease in RBC’s volume corresponding 
with the patent period of murine malaria infection. During the patent period, rapid 
parasite multiplication is experienced culminating in peak parasitaemia and death. 
However, timely intervention with AA administration as a chemoprophylactic has 
salvages Sprague-Dawley (SD) rats from the brink of death to full recovery with 0% 
parasitaemia at Day 12–15 post infection [26].
Peak parasitaemia effects on infection outcomes are compounded by subopti-
mal EPO directed responses such as reduced cellular proliferation (with adequate 
EPO production) to SMA. The inflammasome seem to be the major underlying 
factor driving tissue insensitivity to EPO which leads to SMA even in acute cases. 
Administration of AA to reverses this process by restoring normal hemoglobin (Hb) 
concentrations and Hct.
4.5 Inflammasome drives SMA through hepcidin-ferroportin influence
Iron metabolism is influenced by inflammation of chronic disease through 
hepcidin, the inhibitor of the only known iron exporter. Inflammation drives the 
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synthesis of hepcidin in the liver with cytokines TNF-α, IL-1 and IL-6 playing a 
major role. Interestingly, the hepcidin phenomenon, by driving reduction in iron 
concentrations, is calculated to protect against severe P. falciparum malaria and 
death in young children [113]. Iron deficiency has also been shown to have a 5.5-fold 
protection against placental malaria fatalities [115]. Modulation of Fe2+ concentra-
tion resulting in iron deficiency uses hepcidin synthesis in chronic inflammation 
of malaria. This, therefore, means that inhibition of inflammation mediators will 
also influence hepcidin synthesis and thus remove the metabolic barricade on iron 
export by FPN.
The pleiotropic nature of AA comes to the fore in its ability to attenuate inflam-
matory cytokines (TNF-α. IL-1, IL-6) and combat malarial parasitaemia as well as 
influence iron metabolism through hepcidin. A direct causal relationship between 
hepcidin is and AA is yet to be established. However, it stands to reason that if AA 
is able to attenuate the drivers of hepcidin synthesis, it is also able to influence the 
hormone’s metabolism. Subsequently AA may be able to influence iron metabolism 
through the same process of FPN-hepcidin interaction and reduction of iron export 
from enterocytes, macrophages, hepatocytes and RBC’s. Preservation and recov-
ery of SMA evidenced by normalization of Hct and other RBC indices (reported 
elsewhere) in malaria and parasitaemia reduction by AA indicates the possibility 
of its influence on FPN effects on iron export lost in pRBC’s and was recovered for 
normal intracellular iron to take place.
There is an abundance of FPN on RBCs with effects on RBC iron status, and 
when down-regulated by hepcidin [111, 112] or other inhibitor could therefore 
influence the growth of malaria parasites [116, 117]. However, FPN down-
regulation in malaria mediates parasitaemia proliferation, increase intracellular OS 
from accumulation of haeme Fe2+ [111]. The mutation of FPN Q24H (glutamine 
to histidine switch at position 248) is prevalent in sub-Saharan Africa populations 
with a prevalence of between 2.2–20% [118, 119] renders FPN resistant to hepcidin-
induced degradation [120]. Due to the nonregulated form of the FPN, carriers tend 
to have lower hemoglobin concentrations than normal controls which is consistent 
with findings that high FPN levels in erythroblasts tend to export more iron, dimin-
ish hemoglobin synthesis [121, 122] although it may have protective effect against 
OS as a health benefit to those of African descent. Phytochemical administration in 
malaria and their effects on hepcidin-ferroportin relationship may have the same 
effect.
4.6 Mechanisms of oxidative stress, haemolysis and SMA in malaria
The underlying cause of malarial anemia does not get fully explained by 
dyserythropoiesis as it may have a rapid onset and life-threatening outcomes. A 
plausible explanation of reduced RBC mass includes the haemolysis associated with 
both pRBC’s and npRBC’s that occurs in malaria through changes that take place in 
the cell membranes.
While in the circulation, RBC’s are in constant exposure to endogenous and 
exogenous reactive OS (ROS) with a high potential for cell damage and functional 
impairment through OS. However, ROS effects are minimized by the extensive 
antioxidant system involving non-enzymatic antioxidants of low molecular weight 
(glutathione and ascorbic acids as examples) and enzymatic antioxidants like 
superoxide dismutase, catalase, [123] glutathione reductase [124], and peroxire-
doxin-2 [125, 126]. These antioxidants preserve the life span of RBC’s through 
preserving cell membrane integrity [127]. The antioxidant ability to neutralize 
endogenous ROS is diminished when the blood flows through the microcircula-
tion when hemoglobin (Hb) becomes partially oxygenated [128], more so in 
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malaria-infection cells. Also, partial oxygenation consequence in conformational 
changes of Hb and a dramatic increase in autoxidation of Hb building up with 
attending OS [129, 130]. Un-neutralized ROS in the RBC causes membrane damage 
that impairs their flow through the microcirculation and oxygen delivery to the 
tissues inducing hypoxia and OS generation [131]. Also, cells that come in contact 
with RBC’s containing increased ROS tend to receive OS with subsequent tissue 
damage and inflammation induction [132, 133]. Indications are that RBC’s NADH 
oxidase generate ROS from their membrane locations [134] away from the reach of 
cytoplasmic antioxidant enzymes.
One other none Hb autoxidation related OS leading to RBC deformity is associ-
ated with caspase 3. In the RBC, caspase 3 is activated by oxidative reactions with 
resultant degradation of band 3 [135, 136] which induce the exposure of phosphati-
dylserine, usually located in the inner leaflet of RBC membrane, to the outer surface 
[137]. The resultant histrionic reorganization of the membrane is concomitant with 
decrease in the discoid cell deformability [138] and ultimate haemolysis and RBC’s 
mass reduction.
4.6.1 Oxidative stress, ATPases interaction and SMA
Ionic movement and homeostasis play a critical role in the development of OS 
and ensuing sequalae driving SMA. Inhibition of Ca2+ATPase by OS [139, 140] 
enhances intracellular calcium concentration and activity with resultant RBC 
deformability decreases. Deregulated intracellular calcium concentration tend to 
activate the Gardos channel that results in potassium leakage from the RBC with 
subsequent cation homeostasis destabilization [128, 141] and shrinkage of cell with 
impaired deformability [128].
In malaria the total antioxidant capacity is compromised in the later stages of 
erythrocytic parasite development with membrane damage and breeches occurring 
through increased OS in both in npRBC’s and pRBC’s leading to SMA [142] as the 
RBC seem to be the readily available ROS sink in the disease [2]. This contributes to 
premature RBC’s senescence and poor deformability resulting in the cells’ splenic 
entrapment in the complex macrophage-abundant red pulp fenestrations [142, 143]. 
Oxidative stress is also associated with increased cell volume and density [144]. The 
growing parasite also increases OS and cell density that causes RBC microvesicula-
tion as deformability and flexibility decreases exponentially. Any alterations that 
affects RBC volume and excess surface area tend to affect deformability of the 
cell [128] and this is a common occurrence in malaria leading to haemolysis, RBC 
concentration and SMA.
By interfering with parasite proliferation in murine malaria, AA directly 
contributes to normalizing cell volume and surface areas which aspects preserves 
cellular morphology in malaria [79, 145].
The induction of inducible nitric oxide synthase (iNOS), which increases NO 
synthesis, is closely linked to the inflammatory response in malaria with vascular 
permeability, pulmonary oedema and SMA as outcomes [146]. Increasing NO 
synthesis causes inhibition of the Na+/K+ ATPase with subsequent disturbance of 
water homeostasis in both the npRBC’s, pRBC’s and other tissues [147, 148]. When 
ATPase pump fails there is an accumulation of Na+ in the intracellular compart-
ment of both npRBC’s and pRBC’s with ensuing increased cell volume and surface 
area, membrane rigidity and reduced deformability and infiltrability in the spleen. 
Concomitant to decreased RBC’s filterability is their removal by the spleen leading 
to SMA [27, 149]. ROS and ONOO− from inflammatory processes of malaria may 
have the same effect through oxidation of cell membranes and inhibition of the 
Na+/K+ ATPase pump with consequential SMA [150, 151]. Notwithstanding ATPase 
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inhibition, universal ATP depletion in malaria also uncouples the enzymes followed 
by RBC’s membrane deformities, haemolysis and acute SMA [96, 152].
The fundamental basis of SMA driven by npRBC’s and pRBC’s spleen sequestration 
is underpinned by a synergistic effect of inflammation, OS (ROS and NS) and ATP 
depletion, falls under the ambit of disease processes resolved by the pleiotropic AA 
through its anti-inflammatory, antioxidant and neuroprotective roles [97, 107, 153]. 
There is an intriguing coordination of immune and erythropoietic responses in malaria 
related OS played by the AA administration which speculates extra dimensions in 
controlling parasitaemia and alleviation of SMA.
4.7 Malarial hypoglycaemia expression and the oxidative stress phenotype
Childhood P. falciparum malaria syndrome is preceded by a strong expression 
of hypoglycaemia. The etiology of low glucose concentrations in malaria have been 
accredited to antimalarial drugs like quinine and chloroquine which exhibit insu-
linomimetic action although patients without either intervention or disease have 
shown incapacitating hypoglycaemia [154]. Low blood sugar in malaria has also 
been attributed to increased consumption by growing parasites, but hypoglycaemia 
has been reported in low parasite loads in humans and it has also been shown that 
parasite only consume about 10% of the total plasma glucose even in severe malaria 
[155, 156].
A good and well characterized correlation exists in malaria between hyperlac-
taemia, hypoglycaemia and parasitaemia [157]. The possibility of microvasculature 
obstruction contributing to tissue hypoxia with attendant inefficient glucose 
utilization is plausible. Nevertheless, annotations that normal overall blood flow in 
the brain during periods of coma in malaria have been indicated [158]. Low blood 
flow rates in areas adjacent to high blood flow areas may elucidate the anomaly, 
however, hyperlactaemia requires a different explanation than the microcirculation 
obstruction alone and most likely a synergy with cytokine-induced oxygen unde-
rutilization could be involved [159, 160]. Elevated TNF-α has been associated with 
hypoglycaemia, hyperlactaemia and non-respiratory acidosis (nRA) in a number 
of diseases not related to malaria microvasculature obstruction as well [161]. 
Deliberate intervention with TNF-α in animals models tend to induce the same 
parameters [162, 163].
A causal relationship of hypoglycaemia and TNF-α may be intimated in malaria 
[164]. Borrelia recurrentis infection tends to elevate TNF-α in association with 
inflammation and the triumvirate of hypoglycaemia, non-respiratory acidosis 
and hyperlactaemia although there will not be parasites to excrete lactate or cause 
microvasculature occlusion [165].
Overall, TNF-α seem to be the main orchestrator of inflammation and that the 
anti-inflammatory effects of AA through inhibition of inflammatory mediators 
influence hypoglycaemia amelioration in malaria [30]. Indeed, the biologically 
active pentacyclictriterpenoid compounds oleanolic acid (OA) and maslinic acid 
(MA) have been shown to clear parasitic infection and ameliorate hypoglycaemia 
associated with malaria [106, 166] (Figure 5).
Asiatic acid and MA influence on glucose homeostasis in murine malaria 
involves the attenuation of glycolytic hormone activity by, in part, inhibiting glyco-
gen phosphorylase (GP). Asiatic acid binds at the allosteric activator site naturally 
occupied the physiological activator AMP [30, 167]. This way glycolytic oxidation 
of glucose is reduced through reduced substrate while glycogen synthesis is upregu-
lated. Mitochondrial associated OS may be reduced by inhibiting GP, as happens 
with glycogen synthase kinase 3β inhibition in chronic myocardial ischaemia or 
hypoxia [168], under hypoglycaemic conditions of malaria that would have rather 
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increase glucose mobilization being the norm. Actually, glycogen stores tend to be 
high in animals that are administered with AA as compared to non-treated controls, 
in experiments mentioned above showing glycogen preservation [30]. Inactivation 
of GP not only reduce glycogenolysis but also stimulates glycogen synthesis [167] 
preserving normoglycaemia in malaria and normoinsulinism. Figure 6 indicates the 
allosteric binding site for the inhibitor AA on the dimeric GP.
Figure 6. 
Schematic diagram of the glycogen phosphorylase dimeric molecule, for residues 10–837, viewed down the 
molecular dyad. The catalytic (marked by GLUCOSE in white) and the allosteric (binds AMP and the 
inhibitors AA shown in red) binding sites positions are indicated. The allosteric site is situated at the subunit-
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The Plasmodium parasite, immunological and inflammatory responses, as well 
as chemotherapeutics currently used cause hypoglycaemia in malaria. The anti-
hyperglycaemic, antioxidant, pro-oxidant properties useful in glucose homeostasis, 
observed when AA is administered in malaria, is hinged possibly on its influence 
on controlling hormonal as well as enzymatic aberrations seen in malaria and its 
treatment as explained above, where chloroquine and quinine treatment of malaria 
has been implicated with hyperinsulinism driving hypoglycaemia [169, 170].
A pre-clinical experiment showed that insulin resistance, which invariably 
causes hyperinsulinism [171], was ameliorated after administration of AA in 
malaria [30]. Oral administration of AA at 10 mg kg maintained normoinsulinism 
with reciprocal activity of glucagon in murine malaria in this study. Moreover, AA 
attenuated key glycolytic enzymes in streptozotocin-induced diabetes mellitus 
[172] an aspect that was seen in murine malaria with an overall effect on glucose 
tolerance response. Also, administration of AA terminated the satiation effects of 
high glucagon concentrations [173]. Also, positively modulated by AA administra-
tion, was the alleviation of the otherwise negative effects of malaria on food intake 
and weight gain.
Malaria induced-hypoxia producing hyperlactataemia was also ablated in 
animals that were administered with AA giving an overall high-grade wellbeing as 
opposed to severe malaria infection [174].
5. Malarial acute kidney injury (AKI) and oxidative stress
Kidney injury, acute or chronic, is one of the common differential diagnosis 
of malaria manifesting as syndrome. The diverse presentations and aetiological 
mechanisms of AKI orbit around the properties of pRBC’s on microcirculation, 
hypovolaemia, metabolic derangements or host immunologic responses to infection 
[175–177]. These major pathogenic features are originated by the Plasmodium infec-
tion but may not be limited by the annihilation of the infection. Malaria associated 
AKI may develop after parasite abolition [178] necessitating interventions that 
also eradicate disease effects after parasitaemia clearance. Oxidative stress plays 
a critical role in AKI etiology driven by either the parasite or the immunological 
response to malaria infection which require neutralization in malaria. The source 
of kidney impairment in malaria is through direct tissue injury or inhibition of key 
components of kidney function. Inflammation as an immunological response initia-
tor or vice versa has a close link to AKI development through OS initiators free haem 
Fe2+ and hemozoin which generate OS. Disruption of Na+ transporters by OS in the 
kidney [179] results in sodium wasting syndrome (hypernaturia), hypovolaemia 
with severe dehydration and non-respiratory acidosis leading to hyponatraemia and 
reduced glomerular filtration in malaria infection [180, 181] and malaria treatment 
with chloroquine complicates the disease [182, 183]. Therefore, renoprotective 
agents in the management of malaria AKI are imperative.
By combining the amphiphilic AA and amidated pectin hydrogel matrix in a 
transdermal drug delivery system provides a robust framework for combating 
malaria with renal function and electrolyte preservations [80]. AA-hydrogel matrix 
administration confers “an apply and walk away” once-off treatment for malaria as 
compared to the convoluted regimens of current antimalarial drugs in both dose, 
dosage frequency and administration route, not to mention the oxidative damage 
they bring. The non-nephrotoxicity of AA has been demonstrated in virtual screen-
ing experiments searching for selective inhibitors of 11β-hydroxysteroid dehydroge-
nase 1 (11β-HSD 1) against 11β-hydroxysteroid dehydrogenase 2 (11β-HSD 2) [184]. 
Malaria
16
These enzymes catalyze the interconversion of cortisone and cortisol in humans 
[185]. The isoform 11β-HSD 1 is located in the liver, adipose and brain where it 
converts the inactive cortisone to the active cortisol and 11β-HSD 2 is primarily 
expressed in kidney catalyzing the reverse conversion. The two enzymes provide a 
balance in glucocorticoid metabolism. AA was shown to selectively inhibit 11β-HSD 
1 and not the other isoform. When 11β-HSD 1 is inhibited there is a resultant reduc-
tion in liver gluconeogenesis, lipophilia and there is improved insulin sensitivity 
[186], which may explain the positive influence of AA administration on glucose 
homeostasis in malaria [30]. Therefore, 11β-HSD inhibition by AA works in tandem 
with AA glycogen phosphorylase (GP) inhibition (see above) that preserve glyco-
gen stores. Indeed, the kidney glycogen stores tend to be significantly higher in AA 
administered SD rats than untreated controls. Nevertheless, inhibition of 11β-HSD 
2 leads to sodium retention, hypokalemia and hypertension [187] parameters which 
were not observed with AA administration as compared to controls in the transder-
mal drug delivery of AA studies above.
Further, selective inhibition of 11β-HSD 1 has been suggested to induce anti-
inflammatory effect via the stimulation of haeme oxygenase-1 in LPS-activated 
mice and J774.1 in murine macrophages [188], which may explain the preserva-
tion of renal electrolyte handling that was observed when AA was administered. 
Electrolyte loss in malaria results from inhibition of Na+/K+ ATPase, ENac and 
other electrolyte channels by OS (ROS) in the proximal convoluted tubules which 
results in an increased sodium load reaching the distal convoluted tubes. Excess 
Na+ is as a result lost in the urine in a what is referred to as pseudohypoaldoste-
ronism. Therefore, a dual role of AA may be observed in malarial AKI in that 
the anti-inflammatory and antioxidant effect through the selective inhibition of 
11β-HSD 1 with ultimate reduction in gluconeogenesis which reduce glycolysis 
and in lipid synthesis which reduces lipid peroxidation. Antioxidant capacity is 
seen through AA inhibition of glycogen phosphorylase and glycolysis modula-
tion. Increased insulin insensitivity, that is usually seen in end-stage malaria 
fronted by increasing glucose concentrations and OS, is abolished by AA inhibi-
tion of 11β-HSD 1. Furthermore, glycogen synthase upregulation when glycogen 
phosphorylase is inhibited increases glycogen storage in the kidneys and this 
way restoring optimum renal function and electrolyte handling deranged by OS 
driven AKI. Also, inhibition of 11β-HSD1 promotes autophagy and correlates with 
reduced OS, inflammation [189] which are key pundits in malarial AKI eradicable 
by AA administration.
6. Conclusion
Oxidative stress drives malaria pathophysiology by ROS and NS insults upon 
pRBC’s and npRBC’s from parasitic infection, immunological host response. The 
inflammatory milieu has a cross cutting foot print in malarial syndromes intricately 
intertwining complex disease events, processes and systems to bring about malaria 
disease. Here we have shown how artemisinin, a commonly used antimalarial 
phytotherapeutic and asiatic acid, an experimental antimalarial phytochemical, to 
explain their various interactions in the combat of malarial disease.
Asiatic acid, armed with constitutive antioxidant and oxidative properties 
inhibit parasitic growth, host inflammasome and ameliorates systemic abnormali-
ties in malaria. With selective enzymatic inhibition propensities, apoptotic influ-
ences and amelioration of malaria-induced systemic metabolic derangements, AA 
shows potential as an anti-parasitic, anti-disease, anti-inflammatory, antioxidant, 
immunomodulatory, renoprotective and malarial disease elixir.
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ARF acute renal failure
SMA severe malaria anemia
nRA non-respiratory acidosis
NO nitric oxide
iNOS inducible nitric oxide synthase
ONOO− peroxynitrite
ROS reactive oxygen species
pRBC’s parasitized red blood cells
npRBC’s non-parasitized red blood cells
Author details
Greanious Alfred Mavondo1*, Blessing Nkazimulo Mkhwanazi2, Joy Mavondo3, 
Wisdom Peresuh4 and Obadiah Moyo5
1 National University of Science and Technology, Faculty of Medicine, 
Pathology Department, Bulawayo, Zimbabwe
2 University of KwaZulu Natal (UKZN), Pietermaritzburg, South Africa
3 Imagegate Diagnostics (PL), Bulawayo, Zimbabwe
4 Labnet Laboratories (P/L), Bulawayo, Zimbabwe
5 Chitungwiza General Hospital, Chitungwiza, Zimbabwe
*Address all correspondence to: greanious.mavondo@nust.ac.zw
18
Malaria
[1] Dondorp AM, Omodeo-Salè F, 
Chotivanich K, Taramelli D, White 
NJ. Oxidative stress and rheology 
in severe malaria. Redox Report. 
2003;8:292-294
[2] Becker K, Tilley L, Vennerstrom 
JL, Roberts D, Rogerson S, Ginsburg 
H. Oxidative stress in malaria parasite-
infected erythrocytes: Host-parasite 
interactions. International Journal for 
Parasitology. 2004;34:163-189
[3] Narsaria N, Mohanty C, Das BK, 
Mishra SP, Prasad R. Oxidative stress in 
children with severe malaria. Journal of 
Tropical Pediatrics. 2012;58:147-150
[4] Potter SM, Mitchell AJ, Cowden WB, 
Sanni LA, Dinauer M, Haan JB, et al. 
Phagocyte-derived reactive oxygen 
species do not influence the progression 
of murine blood-stage malaria 
infections. Infection and Immunity. 
2005;73:4941-4947
[5] Keller CC, Kremsner PG, Hittner JB, 
Misukonis MA, Weinberg JB, Perkins 
DJ. Elevated nitric oxide production 
in children with malarial anemia: 
Hemozoin-induced nitric oxide synthase 
type 2 transcripts and nitric oxide in 
blood mononuclear cells. Infection and 
Immunity. 2004;72:4868-4873
[6] Sohail M, Kaul A, Raziuddin M, 
Adak T. Decreased glutathione-S-
transferase activity: Diagnostic and 
protective role in vivax malaria. Clinical 
Biochemistry. 2007;40:377-382
[7] Guha M, Kumar S, Choubey V, Maity 
P. Apoptosis in liver during malaria: 
Role of oxidative stress and implication 
of mitochondrial pathway. The FASEB 
Journal. 2006;20:E439-E449
[8] Kumar S, Bandyopadhyay U. Free 
heme toxicity and its detoxification 
systems in human. Toxicology Letters. 
2005;157:175-188
[9] Koppenol WH. The Haber-
Weiss cycle—70 years later. Redox 
Report. 2001;6(4):229-234. DOI: 
10.1179/135100001101536373
[10] Haber F, Weiss J. Über die 
Katalyse des hydroperoxydes (on 
the catalysis of hydroperoxide). Die 
Naturwissenschaften. 1932;20(51): 
948-950. DOI: 10.1007/BF01504715
[11] Bedard K, Krause KH. The 
NOX family of ROS-generating 
NADPH oxidases: Physiology and 
pathophysiology. Physiological Reviews. 
2007;87:245-313
[12] Bhattacharyya A, Chattopadhyay R, 
Mitra S, Crowe SE. Oxidative stress as 
an essential factor in the pathogenesis 
of gastrointestinal mucosal diseases. 
Physiological Reviews. 2014;94:329-354. 
DOI: 10.1152/physrev.00040.2012
[13] Ibrahim CB, Aroniadis OC, 
Brandt LJ. On the role of ischemia in 
the pathogenesis of IBD: A review. 
Inflammatory Bowel Diseases. 
2010;16:696-702
[14] Baud L, Ardaillou R. Involvement 
of reactive oxygen species in kidney 
damage. British Medical Bulletin. 
1993;49:62-629
[15] Forbes JM, Coughlan MT, Cooper 
ME. Oxidative stress as a major culprit 
in kidney disease in diabetes. Diabetes. 
2008;57:1446-1454
[16] Colgan SP, Taylor CT. Hypoxia: 
An alarm signal during intestinal 
inflammation. Nature Reviews. 
Gastroenterology & Hepatology. 
2010;7:281-287
[17] Iuchi T, Akaike M, Mitsui T, 
Ohshima Y, Shintani Y, Azuma H, 
et al. Glucocorticoid excess induces 
superoxide production in vascular 
endothelial cells and elicits vascular 
References
19
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
endothelial dysfunction. Circulation 
Research. 2003;92:81-87
[18] Faraci FM. Oxidative stress: The 
curse that underlies cerebral vascular 
dysfunction? Stroke. 2005;36:186-188
[19] Butterfield DA, Reed TT, Perluigi 
M, De MC, Coccia R, Keller JN, et al. 
Elevated levels of 3-nitrotyrosine in 
brain from subjects with amnestic mild 
cognitive impairment: Implications for 
the role of nitration in the progression 
of Alzheimer’s disease. Brain Research. 
2007;1148:243-248
[20] Hamel E, Nicolakakis N, 
Aboulkassim T, Ongali B, 
Tong XK. Oxidative stress and 
cerebrovascular dysfunction in 
mouse models of Alzheimer’s 
disease. Experimental Physiology. 
2008;93:116-120
[21] Vandermosten L, Pham T-T, 
Possemiers H, Knoops S, Van Herck 
E, Deckers J, et al. Experimental 
malaria-associated acute respiratory 
distress syndrome is dependent on the 
parasite-host combination and coincides 
with normocyte invasion. Malaria 
Journal. 2018;17:102. DOI: 10.1186/
s12936-018-2251-3
[22] Kerlin DH, Gatton ML. Preferential 
invasion by Plasmodium merozoites and 
the self-regulation of parasite burden. 
PLoS One. 2013;8:e57434
[23] Mavondo GA. Malaria disease 
perspective and an opinion: Should 
malaria treatment target the parasite 
or the malarial pathophysiology 
generated by the parasite or both? EC 
Microbiology. 2017;7(5):149-154
[24] Markus MB. Malaria: Origin of 
the term “hypnozoite”. Journal of the 
History of Biology. 2011;44(4):781-786. 
DOI: 10.1007/s10739-010-9239-3
[25] Markus MB. Do hypnozoites 
cause relapse in malaria? Trends in 
Parasitology. 2015;31(6):239-245. DOI: 
10.1016/j.pt.2015.02.003
[26] Mavondo GA, Mkhwananzi BN, 
Mabandla MV, Musabayane CT. Asiatic 
acid influences parasitaemia reduction 
and ameliorates malaria anaemia in 
P. berghei infected Sprague-Dawley 
male rats. BMC Complementary and 
Alternative Medicine. 2016;16(1):357. 
DOI: 10.1186/s12906-016-1338-z
[27] Buffet PA, Safeukui I, Deplaine 
G, Brousse V, Prendki V, Thellier M, 
et al. The pathogenesis of Plasmodium 
falciparum malaria in humans: Insights 
into splenic physiology. Blood. 
2011;117(2):381-392. DOI: 10.1182/
blood-2010-04-202911
[28] Khan R, Quaiser S, Haque SF. 
Malarial acute kidney injury: 
Prognostic markers. Annals of 
Tropical Medicine and Public Health. 
2013;6:280-284
[29] Onwuamaegbu ME, Henein M, 
Coats AJ. Cachexia in malaria and heart 
failure: Therapeutic considerations in 
clinical practice. Postgraduate Medical 
Journal. 2004;80:642-649
[30] Mavondo GA, Mkhwananzi BN,  
Mabandla MV, Musabayane CT. 
Asiatic acid influences glucose 
homeostasis in P. berghei murine malaria 
infected Sprague Dawley rats. African 
Journal of Traditional, Complementary, 
and Alternative Medicines. 2016; 
13(5):91-101. DOI: 10.21010/ajtcam.
v13i5.13
[31] White NJ, Warrell DA, 
Chanthanavich P, Looareesuwan 
S, Warrell MJ, Krishna S. Severe 
hypoglycaemia and hyperinsulinaemia 
in falciparum malaria. The New England 
Journal of Medicine. 1983;309:61-62
[32] Van den Steen PE, Deroost K, 
Deckers J, Van Herck E, Struyf S, 
Opdenakker G. Pathogenesis of malaria-
associated acute respiratory distress 
Malaria
20
syndrome. Trends in Parasitology. 
2013;29:346-358
[33] Mohan A, Sharma SK, Bollinen i S. 
Acute lung injury and acute respiratory 
distress syndrome in malaria. Journal of 
Vector Borne Diseases. 2008;45: 
179-193
[34] Lin J, Sodenkamp J, Cunningham D, 
Deroost K, Tshitenge TC, McLaughlin 
S. Signatures of malaria-associated 
pathology revealed by highresolution 
whole-blood transcriptomics in a rodent 
model of malaria. Scientific Reports. 
2017;7:41722
[35] Kateera F, Ingabire CH, Hakizimana 
E, Kalinda P, Mens PF, Grobusch MP. 
Malaria, anaemia and under-nutrition: 
Three frequently co-existing conditions 
among preschool children in rural 
Rwanda. Malaria Journal. 2015;14:440
[36] Thien H, Kager P, Sauerwein 
H. Hypoglycemia in falciparum 
malaria: Is fasting an unrecognized and 
insufficiently emphasized risk factor. 
Trends in Parasitology. 2006;22:410-415
[37] Mishra SK, Mahanta KC, Mohanty 
S. Malaria associated acute renal failure-
experience from Rourkela, eastern 
India. Journal of the Indian Medical 
Association. 2008;106:640-654
[38] Day NP, Phu NH, Mai NT, Chau 
TT, Loc PP. The pathophysiologic and 
prognostic significance of acidosis 
in severe adult malaria. Critical Care 
Medicine. 28:1833-1840
[39] Sharma L, Shukla G. Placental 
malaria: A new insight into the 
pathophysiology. Frontiers in 
Medicine. 2017;4:117. DOI: 10.3389/
fmed.2017.00117
[40] Klayman DL. Qinghaosu 
(artemisinin): An antimalarial 
drug from China. Science. 
1985;228:1049-1055
[41] Antoine T, Fisher N, Amewu 
R, O’Neill PM, Ward SA, Biagini 
GA. Rapid kill of malaria parasites 
by artemisinin and semi-synthetic 
endoperoxides involves ROS-dependent 
depolarization of the membrane 
potential. The Journal of Antimicrobial 
Chemotherapy. 2013;69(4):1005-1016. 
DOI: 10.1093/jac/dkt486
[42] Cui L, Su X-Z. Discovery, 
mechanisms of action and combination 
therapy of artemisinin. Expert 
Review of Anti-infective Therapy. 
2009;7(8):999-1013. DOI: 10.1586/
eri.09.68
[43] O’Neill PM, Barton VE, Ward 
SA. The molecular mechanism of action 
of artemisinin-the debate continues. 
Molecules. 2010;15:1705-1721
[44] Meshnick SR, Yang YZ, Lima 
V. Iron-dependent free radical 
generation from the antimalarial agent 
artemisinin (qinghaosu). Antimicrobial 
Agents and Chemotherapy. 
1993;37:1108-1114
[45] Meshnick SR, Thomas A, Ranz 
A. Artemisinin (qinghaosu): The role 
of intracellular hemin in its mechanism 
of antimalarial action. Molecular 
and Biochemical Parasitology. 
1991;49:181-189
[46] Posner GH, Oh CH, Wang D. 
Mechanism-based design, synthesis, 
and in vitro antimalarial testing 
of new 4-methylated trioxanes 
structurally related to artemisinin: 
The importance of a carbon-centered 
radical for antimalarial activity. 
Journal of Medicinal Chemistry. 
1994;37:1256-1258
[47] Posner GH, Wang D, Cumming 
JN. Further evidence supporting the 
importance of and the restrictions 
on a carbon-centered radical for high 
antimalarial activity of 1,2,4-trioxanes 
like artemisinin. Journal of Medicinal 
Chemistry. 1995;38:2273-2275
21
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
[48] Butler AR, Gilbert BC, Hulme 
P. EPR evidence for the involvement 
of free radicals in the iron-catalysed 
decomposition of qinghaosu 
(artemisinin) and some derivatives; 
antimalarial action of some polycyclic 
endoperoxides. Free Radical Research. 
1998;28:471-476
[49] Wu W-M, Wu Y, Y-L W. Unified 
mechanistic framework for the Fe(II)-
induced cleavage of qinghaosu and 
derivatives/analogues. The first spin-
trapping evidence for the previously 
postulated secondary C-4 radical. 
Journal of the American Chemical 
Society. 1998;120:3316-3325
[50] Robert A, Benoit-Vical F, Claparols 
C, Meunier B. The antimalarial 
drug artemisinin alkylates heme 
in infected mice. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2005;102(38):13676-13680
[51] Wu Y. How might qinghaosu 
(artemisinin) and related compounds 
kill the intraerythrocytic malaria 
parasite? a chemist’s view. Accounts of 
Chemical Research. 2002;35:255-259
[52] Shi C, Li H, Yang Y, Hou L. Anti-
inflammatory and immunoregulatory 
functions of artemisinin and its 
derivatives. Mediators of Inflammation. 
2015;2015:7. DOI: 10.1155/2015/435713
[53] Zhou WL, Wu JM, Wu QL. A 
novel artemisinin derivative, 
3-(12-beta-artemisininoxy) phenoxyl 
succinic acid (SM735), mediates 
immunosuppressive effects in vitro and 
in vivo. Acta Pharmacologica Sinica. 
2005;26(11):1352-1358
[54] Wang J-X, Tang W, Zhou R. The 
new water-soluble artemisinin 
derivative SM905 ameliorates collagen-
induced arthritis by suppression of 
inflammatory and Th17 responses. 
British Journal of Pharmacology. 
2008;153(6):1303-1310
[55] Wang J-X, Tang W, Yang Z-S. 
Suppressive effect of a novel water-
soluble artemisinin derivative SM905 
on T cell activation and proliferation 
in vitro and in vivo. European Journal of 
Pharmacology. 2007;564(1-3):211-218
[56] Zhao YG, Wang Y, Guo Z. 
Dihydroartemisinin ameliorates 
inflammatory disease by its reciprocal 
effects on Th and regulatory T 
cell function via modulating the 
mammalian target of rapamycin 
pathway. Journal of Immunology. 
2012;189(9):4417-4425
[57] Hou L-F, He S-J, Li X. Sm934 treated 
lupus-prone NZB×NZW F1 mice by 
enhancing macrophage interleukin-10 
production and suppressing pathogenic 
T cell development. PLoS One. 
2012;7(2):e32424
[58] Hou L-F, He S-J, Li X. Oral 
administration of artemisinin 
analog SM934 ameliorates lupus 
syndromes in MRL/lpr mice 
by inhibiting Th1 and Th17 cell 
responses. Arthritis and Rheumatism. 
2011;63(8):2445-2455
[59] Vennerstrom JL, Arbe-Barnes 
S, Brun R. Identification of an 
antimalarial synthetic trioxolane 
drug development candidate. Nature. 
2004;430(7002):900-904
[60] Mercer AE, Maggs JL, Sun 
X-M. Evidence for the involvement 
of carbon-centered radicals in the 
induction of apoptotic cell death 
by artemisinin compounds. The 
Journal of Biological Chemistry. 
2007;282(13):9372-9382
[61] Golenser J, Waknine JH, Krugliak 
M, Hunt NH, Grau GE. Current 
perspectives on the mechanism of action 
of artemisinins. International Journal 
for Parasitology. 2006;36(14):1427-1441
[62] Alberola-Ila J, Takaki S, Kerner JD, 
Perlmutter RM. Differential signaling by 
Malaria
22
lymphocyte antigen receptors. Annual 
Review of Immunology. 1997;15:125-154
[63] Lea NC, Orr SJ, Stoeber K. 
Commitment point during G0 → 
G1 that controls entry into the cell 
cycle. Molecular and Cellular Biology. 
2003;23(7):2351-2361
[64] Li Y. Qinghaosu (artemisinin): 
Chemistry and pharmacology. 
Acta Pharmacologica Sinica. 
2012;33(9):1141-1146
[65] Wang J-X, Tang W, Shi 
L-P. Investigation of the 
immunosuppressive activity of 
artemether on T-cell activation and 
proliferation. British Journal of 
Pharmacology. 2007;150(5):652-661
[66] Yang Z-S, Wang J-X, Zhou 
Y, Zuo J-P, Li Y. Synthesis and 
immunosuppressive activity of 
new artemisinin derivatives. 
Part 2: 2-[12(beta or alpha)-
dihydroartemisinoxymethyl(or 
1′-ethyl)]phenoxyl propionic acids 
and esters. Bioorganic & Medicinal 
Chemistry. 2006;14(23):8043-8049
[67] Zhang J-X, Wang J-X, Zhang 
Y. Synthesis and immunosuppressive 
activity of new artemisinin derivatives 
containing polyethylene glycol group. 
Yaoxue Xuebao. 2006;41(1):65-70
[68] Hou L-F, He S-J, Wang J-X. SM934, 
a water-soluble derivative of 
arteminisin, exerts immunosuppressive 
functions in vitro and in vivo. 
International Immunopharmacology. 
2009;9(13-14):1509-1517
[69] Noori S, Hassan ZM, Rezaei B, 
Rustaiyan A, Habibi Z, Fallahian 
F. Artemisinin can inhibit the 
calmodulin-mediated activation of 
phosphodiesterase in comparison 
with cyclosporin A. International 
Immunopharmacology. 
2008;8(13-14):1744-1747
[70] Noori S, Hassan ZM, 
Taghikhani M, Rezaei B, Habibi 
Z. Dihydroartemisinin can inhibit 
calmodulin, calmodulin-dependent 
phosphodiesterase activity and 
stimulate cellular immune responses. 
International Immunopharmacology. 
2010;10(2):213-217
[71] Wang J-X, Hou L-F, Yang Y, 
Tang W, Li Y, Zuo JP. SM905, an 
artemisinin derivative, inhibited 
NO and proinflammatory cytokine 
production by suppressing MAPK 
and NF-B pathways in RAW 264.7 
macrophages. Acta Pharmacologica 
Sinica. 2009;30(10):1428-1435
[72] He Y, Fan J, Lin H. The anti-malaria 
agent artesunate inhibits expression 
of vascular endothelial growth factor 
and hypoxia-inducible factor-1alpha in 
human rheumatoid arthritis fibroblast-
like synoviocyte. Rheumatology 
International. 2015;31(1):53-60
[73] Xu H, He Y, Yang X. Anti-malarial 
agent artesunate inhibits TNF-alpha-
induced production of proinflammatory 
cytokines via inhibition of NF-kB 
and PI3 kinase/Akt signal pathway in 
human rheumatoid arthritis fibroblast-
like synoviocytes. Rheumatology. 
2007;46(6):920-926
[74] Olliaro PL, Haynes RK, Meunier 
B, Yuthavong Y. Possible modes 
of action of the artemisinin-type 
compounds. Trends in Parasitology. 
2001;17(3):122-126
[75] Eckstein-Ludwig U, Webb RJ, van 
Goethem IDA. Artemisinins target 
the SERCA of Plasmodium falciparum. 
Nature. 2003;424(6951):957-961
[76] Uhlemann A-C, Cameron A, 
Eckstein-Ludwig U. A single amino acid 
residue can determine the sensitivity 
of SERCAs to artemisinins. Nature 
Structural & Molecular Biology. 
2005;12(7):628-629
23
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
[77] Jung M, Kim H, Ki YN, Kyoung 
TN. Three dimensional structure 
of Plasmodium falciparum Ca2+-
ATPase(PfATP6) and docking of 
artemisinin derivatives to PfATP6. 
Bioorganic & Medicinal Chemistry 
Letters. 2005;15(12):2994-2997
[78] Lv J, Sharma A, Zhang T, Wu 
Y, Ding X. Pharmacological review 
on asiatic acid and its derivatives: 
A potential compound. SLAS 
Technology. 2018;23(2):111-127. DOI: 
10.1177/2472630317751840
[79] Mavondo GA, Musabayane 
CT. Asiatic acid-pectin hydrogel matrix 
patch transdermal delivery system 
influences parasitaemia suppression and 
inflammation reduction in P. berghei 
murine malaria infected Sprague-Dawley 
rats. Asian Pacific Journal of Tropical 
Medicine. 2016;9(12):1172-1180. DOI: 
10.1016/j.apjtm.2016.10.008
[80] Mavondo GA, Musabayane 
CT. Transdermal drug delivery of 
asiatic acid influences renal function 
and electrolyte handling in Plasmodium 
berghei-infected Sprague-Dawley male 
rats. Journal of Diseases and Medicinal 
Plants. 2018;4(1):18-29. DOI: 10.11648/j.
jdmp.20180401.13
[81] Mavondo GA, Kasvosve I. 
Antimalarial phytochemicals: 
Delineation of the triterpene asiatic 
acid malarial anti-disease and 
pathophysiological remedial activities—
Part I. Journal of Infectious Disease and 
Pathology. 2017;1:104
[82] Mavondo GA, Kasvosve I. 
Antimalarial phytochemicals: 
Delineation of the triterpene asiatic 
acid malarial anti-disease and 
pathophysiological remedial activities—
Part II. Journal of Infectious Disease and 
Pathology. 2017;1:103
[83] Haldar K, Mohandas N. Malaria, 
erythrocytic infection and anemia. 
Hematology. American Society of 
Hematology. Education Program. 
2009;1:87-93
[84] Skorokhod OA, Caione L, 
Marrocco T, Migliardi G, Barrera 
V, Arese P, et al. Inhibition of 
erythropoiesis in malaria anemia: 




[85] Fisher JW. Erythropoietin: 
Physiology and pharmacology update. 
Experimental Biology and Medicine. 
2003;228:1-14
[86] Wu H, Klingmuller U, Besmer 
P, Lodish HF. Interaction of the 
erythropoietin and stem-cell-factor 
receptors. Nature. 1995;377:242-246
[87] Bachmann S, LeHir M, Eckardt 
KU. Co-localization of erythropoietin 
mRNA and ecto-5′-nucleotidase 
immunoreactivity in peritubular cells of 
rat renal cortex indicates that fibroblasts 
produce erythropoietin. The Journal 
of Histochemistry and Cytochemistry. 
1993;41:335-341
[88] Maxwell PH, Osmond MK, Pugh 
CW, Heryet A, Nicholls LG, Tan 
CC, et al. Identification of the renal 
erythropoietin-producing cells using 
transgenic mice. Kidney International. 
1993;44:1149-1162
[89] Fisher JW, Koury S, Ducey T, 
Mendel S. Erythropoietin production 
by interstitial cells of hypoxic monkey 
kidneys. British Journal of Haematology. 
1996;95:27-32
[90] Mavondo GA, Musabayane CT. 
Transdermal drug delivery of asiatic 
acid influences renal function and 
electrolyte handling in plasmodium 
berghei-infected sprague-dawley male 




[91] Ghosh K, Ghosh K. Pathogenesis 
of anemia in malaria: A concise 
review. Parasitology Research. 
2007;101:1463-1469
[92] Perkins DJ, Were T, Davenport 
GC, Kempaiah P, Hittner JB, 
Ong’echa JM. Severe malarial anemia: 
Innate immunity and pathogenesis. 
International Journal of Biological 
Sciences. 2011;7:1427-1442
[93] McDevitt MM, Xie J, 
Shanmugasundaram G, Griffith J, Liu 
A, McDonald C, et al. A critical role 
for the host mediator macrophage 
migration inhibitory factor in the 
pathogenesis of malarial anaemia. The 
Journal of Experimental Medicine. 
2006;203:1185-1196
[94] Pradhan P. Malarial anaemia 
and nitric oxide induced 
megaloblastic anaemia: A review 
on the causes of malarial anaemia. 
Journal of Vector Borne Diseases. 
2009;46:100-108
[95] Chang KH, Tam M, Stevenson 
MM. Inappropriately low reticulocytosis 
in severe malarial anemia correlates 
with suppression in the development 
of late erythroid precursor. Blood. 
2004;103:3727-3735
[96] Autino B, Corbett Y, Castelli F, 
Taramelli D. Pathogenesis of malaria 
in tissues and blood. Mediterranean 
Journal of Hematology and Infectious 
Diseases. 2012;4(1):e2012061. DOI: 
10.4084/MJHID.2012.061
[97] Huang SS, Chiu CS, Chen HJ, 
Hou WC, Sheu MJ. Antinociceptive 
activities and the mechanisms of anti-
inflammation of asiatic acid in mice. 
Evidence-Based Complementary and 
Alternative Medicine. 2011;2011:10. 
DOI: 10.1155/2011/895857
[98] Chen H, Hua X-M, Ze B-C,  
Wang B, Wei L. The anti-
inflammatory effects of asiatic acid 
in lipopolysaccharide-stimulated 
human corneal epithelial cells. 
International Journal of Ophthalmology. 
2017;10(2):179-185. DOI: 10.18240/
ijo.2017.02.01
[99] Xiao W, Jiang W, Li K, Hu Y, Li 
S, Zhou L, et al. Protective effect of 
asiatic acid in an experimental cerulein-
induced model of acute pancreatitis in 
mice. American Journal of Translational 
Research. 2017;9(8):3842-3852
[100] Nemeth E, Rivera S, Gabayan 
V, Keller C, Taudorf S, Pedersen BK, 
et al. IL-6 mediates hypoferremia of 
inflammation by inducing the synthesis 
of the iron regulatory hormone 
hepcidin. The Journal of Clinical 
Investigation. 2004;113(9):1271-1276. 
DOI: 10.1172/JCI200420945
[101] Laftah AH, Sharma N, Brookes 
MJ, McKie AT, Simpson RJ, Iqbal 
TH, et al. Tumour necrosis factor α 
causes hypoferraemia and reduced 
intestinal iron absorption in mice. The 
Biochemical Journal. 2006;397(1):61-67. 
DOI: 10.1042/BJ20060215
[102] Amre Nasr A, Allam G, Hamid 
O, Al-Ghamdi A. IFN-gamma and 
TNF associated with severe falciparum 
malaria infection in Saudi pregnant 
women. Malaria Journal. 2014;13:314. 
DOI: 10.1186/1475-2875-13-314
[103] Lamikanra AA, Merryweather-
Clarke AT, Tipping AJ, Roberts 
DJ. Distinct mechanisms of 
inadequate erythropoiesis induced 
by tumor necrosis factor alpha 
or malarial pigment. PLoS One. 
2015;10(4):e0127124. DOI: 10.1371/
journal.pone.0127124
[104] Boeuf PS, Loizon S, Awandare GA, 
Tetteh JKA, Addae MM, Adjei GO, et al. 
Insights into deregulated TNF and IL-10 
production in malaria: Implications for 
understanding severe malarial anaemia. 
Malaria Journal. 2012;11:253. DOI: 
10.1186/1475-2875-11-253©
25
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
[105] Nussenblatt V, Mukasa G, Metzger 
A, Ndeezi G, Garrett E, Semba 
RD. Anemia and interleukin-10, 
tumor necrosis factor alpha, and 
erythropoietin levels among children 
with acute, uncomplicated Plasmodium 
falciparum malaria. Clinical and 
Diagnostic Laboratory Immunology. 
2001;8(6):1164-1170. DOI: 10.1128/
CDLI.8.6.1164-1170.2001
[106] Sibiya H, Musabayane CT, 
Mabandla MV. Transdermal delivery 
of oleanolic acid attenuates pro-
inflammatory cytokine release and 
ameliorates anaemia in P. berghei 
malaria. Acta Tropica. 2017;171:24-29. 
DOI: 10.1016/j.actatropica.2017.03.005
[107] Ramachandran V, Saravanan 
R. Asiatic acid prevents lipid 
peroxidation and improves antioxidant 
status in rats with streptozotocin-
induced diabetes. Journal of Functional 
Foods. 2013;5:1077-1087
[108] Nanami M, Ookawara T, 
Otaki Y, Ito K, Moriguchi R, 
Miyagawa K, et al. Tumor necrosis 
factor-α–induced iron sequestration 
and oxidative stress in human 
endothelial cells. Arteriosclerosis, 
Thrombosis, and Vascular Biology. 
2005;25:2495-2501. DOI: 10.1161/01.
ATV.0000190610.63878.20
[109] Nemeth E, Tuttle MS, Powelson 
J, Vaughn MB, Donovan A, Ward DM, 
et al. Hepcidin regulates cellular iron 
efflux by binding to ferroportin and 
inducing its internalization. Science. 
2004;306(5704):2090-2093
[110] de Mast Q , Syafruddin D, Keijmel 
S, Riekerink TO, Deky O, Asih PB, 
et al. Increased serum hepcidin and 
alterations in blood iron parameters 
associated with asymptomatic P. 
falciparum and P. vivax malaria. 
Haematologica. 2010;95:1068-1074
[111] Zhang DL, Wu J, Shah BN, 
Greutélaers KC, Ghosh MC, Ollivierre 
H, et al. Erythrocytic ferroportin 
reduces intracellular iron accumulation, 
hemolysis, and malaria risk. Science. 
2018;359(6383):1520-1523. DOI: 
10.1126/science.aal2022
[112] Zhang D-L, Ghosh MC, Ollivierre 
H, Li Y, Rouault TA. Ferroportin 
deficiency in erythroid cells causes 
serum iron deficiency and promotes 
hemolysis due to oxidative stress. Blood. 
2018, 2018;(4):842997. DOI: 10.1182/
blood-2018-04-842997
[113] Gwamaka M, Kurtis JD, 
Sorensen BE, Holte S, Morrison R, 
Mutabingwa TK, et al. Iron deficiency 
protects against severe plasmodium 
falciparum malaria and death in young 
children. Clinical Infectious Diseases. 
2012;54(8):1137-1144. DOI: 10.1093/cid/
cis010
[114] Prasetyani MA, de Mast Q , 
Afeworki R, Kaisar MMM, Stefanie 
D, Sartono E, et al. Effect of a short 
course of iron polymaltose on 
acquisition of malarial parasitaemia in 
anaemic Indonesian schoolchildren: 
A randomized trial. Malaria 
Journal. 2017;16:50. DOI: 10.1186/
s12936-017-1691-5
[115] Kabyemela ER, Fried M, Kurtis JD, 
Mutabingwa TK, Duffy PE. Decreased 
susceptibility to Plasmodium falciparum 
infection in pregnant women with iron 
deficiency. The Journal of Infectious 
Diseases. 2008;198:163-166
[116] Clark MA, Goheen MM, Fulford 
A, Prentice AM, Elnagheeb MA, 
Patel J, et al. Host iron status and iron 
supplementation mediate susceptibility 
to erythrocytic stage Plasmodium 
falciparum. Nature Communications. 
2014;5:4446. DOI: 10.1038/
ncomms5446
[117] Zhang DL, Ghosh MC, Rouault 
TA. The physiological functions 
of iron regulatory proteins in iron 
homeostasis—An update. Frontiers 
Malaria
26
in Pharmacology. 2014;5:124. DOI: 
10.3389/fphar.2014.00124
[118] Kasvosve I, Gomo ZAR, Nathoo 
KJ, Matibe P, Mudenge B, Loyevsky 
M, et al. Effect of ferroportin Q248H 
polymorphism on iron status in 
African children. The American 
Journal of Clinical Nutrition. 
2005;82:1102-1106
[119] Gordeuk VR, Caleffi A, Corradini 
E, Ferrara F, Jones RA, Castro O, et al. 
Iron overload in Africans and African-
Americans and a common mutation 
in the SCL40A1 (ferroportin 1) gene. 
Blood Cells, Molecules & Diseases. 
2003;31(3):299-304
[120] Nekhai S, Xu M, Foster A, 
Kasvosve I, Diaz S, Machado 
RF, et al. Reduced sensitivity of 
the ferroportin Q248H mutant 
to physiological concentrations 
of hepcidin. Haematologica. 
2013;98(3):455-463. DOI: 10.3324/
haematol.2012.066530
[121] Zhang DL, Hughes RM, Ollivierre-
Wilson H, Ghosh MC, Rouault TA. A 
ferroportin transcript that lacks an 
iron-responsive element enables 
duodenal and erythroid precursor cells 
to evade translational repression. Cell 
Metabolism. 2009;9(5):461-473. DOI: 
10.1016/j.cmet.2009.03.006
[122] Zhang D-L, Senecal T, Ghosh MC, 
Ollivierre-Wilson H, Tu T, Rouault 
TA. Hepcidin regulates ferroportin 
expression and intracellular iron 
homeostasis of erythroblasts. Blood. 
2011;118:2868-2877. DOI: 10.1182/
blood-2011-01-330241
[123] Gonzales R, Auclair C, Voisin 
E, Gautero H, Dhermy D, Boivin 
P. Superoxide dismutase, catalase, 
and glutathione peroxidase in red 
blood cells from patients with 
malignant diseases. Cancer Research. 
1984;44:4137-4139
[124] Nagababu E, Chrest FJ, 
Rifkind JM. Hydrogen-peroxide-
induced heme degradation in red 
blood cells: The protective roles of 
catalase and glutathione peroxidase. 
Biochimica et Biophysica Acta. 
2003;1620:211-217. DOI: 10.1016/
S0304-4165(02)00537-8
[125] Nagababu E, Mohanty JG, 
Friedman JS, Rifkind JM. Role of 
peroxiredoxin-2 in protecting RBCs 
from hydrogen peroxide-induced 
oxidative stress. Free Radical 
Research. 2013;47:164-171. DOI: 
10.3109/10715762.2012.756138
[126] Lee TH, Kim SU, Yu SL, Kim SH, 
Park DS, Moon HB. Peroxiredoxin 
II is essential for sustaining life 
span of erythrocytes in mice. Blood. 
2003;101:5033-5038. DOI: 10.1182/
blood-2002-08-2548
[127] Nagababu E, Mohanty JG, 
Bhamidipaty S, Ostera GR, Rifkind 
JM. Role of the membrane in the 
formation of heme degradation 
products in red blood cells. Life 
Sciences. 2010;86:133-138. DOI: 
10.1016/j.lfs.2009.11.015
[128] Mohanty JG, Nagababu E, Rifkind 
JM. Red blood cell oxidative stress 
impairs oxygen delivery and induces 
red blood cell aging. Frontiers in 
Physiology. 2014;5:84. DOI: 10.3389/
fphys.2014.00084
[129] Balagopalakrishna C, 
Manoharan PT, Abugo OO, Rifkind 
JM. Production of superoxide from 
hemoglobin-bound oxygen under 
hypoxic conditions. Biochemistry. 
1996;35:6393-6398. DOI: 10.1021/
bi952875+
[130] Abugo OO, Rifkind JM. Oxidation 
of hemoglobin and the enhancement 
produced by nitroblue tetrazolium. 
The Journal of Biological Chemistry. 
1994;269:24845-24853
27
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
[131] Nagababu E, Gulyani S, Earley 
CJ, Cutler RG, Mattson MP, Rifkind 
JM. Iron-deficiency anaemia enhances 
red blood cell oxidative stress. Free 
Radical Research. 2008;42:824-829. 
DOI: 10.1080/10715760802459879
[132] Kiefmann R, Rifkind JM, Nagababu 
E, Bhattacharya J. Red blood cells induce 
hypoxic lung inflammation. Blood. 
2008;111:5205-5214. DOI: 10.1182/
blood-2007-09-113902
[133] Huertas A, Das SR, Emin M, 
Sun L, Rifkind JM, Bhattacharya J. 
Erythrocytes induce proinflammatory 
endothelial activation in hypoxia. 
American Journal of Respiratory Cell 
and Molecular Biology. 2013;48:78-86. 
DOI: 10.1165/rcmb.2011-0402OC
[134] George A, Pushkaran S, 
Konstantinidis DG, Koochaki S, Malik 
P, Mohandas N. Erythrocyte NADPH 
oxidase activity modulated by Rac 
GTPases, PKC, and plasma cytokines 
contributes to oxidative stress in sickle 
cell disease. Blood. 2013;121:2099-2107. 
DOI: 10.1182/blood-2012-07-441188
[135] Clementi ME, Giardina B, Colucci 
D, Galtieri A, Misiti F. Amyloid-beta 
peptide affects the oxygen dependence 
of erythrocyte metabolism: A role for 
caspase 3. The International Journal 
of Biochemistry & Cell Biology. 
2007;39:727-735. DOI: 10.1016/j.
biocel.2006.11.013
[136] Mandal D, Baudin-Creuza V, 
Bhattacharyya A, Pathak S, Delaunay J, 
Kundu M. Caspase 3-mediated proteolysis 
of the N-terminal cytoplasmic domain 
of the human erythroid anion exchanger 
1 (band 3). The Journal of Biological 
Chemistry. 2003;278:52551-52558. DOI: 
10.1074/jbc.M306914200
[137] Mandal D, Mazumder A, Das P, 
Kundu M, Basu J. Fas-, caspase 8-, and 
caspase 3-dependent signaling regulates 
the activity of the aminophospholipid 
translocase and phosphatidylserine 
externalization in human erythrocytes. 
The Journal of Biological Chemistry. 
2005;280:39460-39467. DOI: 10.1074/
jbc.M506928200
[138] Fens MH, van WR, Andringa 
G, van Rooijen KL, Dijstelbloem 
HM, Rasmussen JT. A role for 
activated endothelial cells in red 
blood cell clearance: Implications 
for vasopathology. Haematologica. 
2012;97:500-508. DOI: 10.3324/
haematol.2011.048694
[139] Kiefer CR, Snyder LM. 
Oxidation and erythrocyte 
senescence. Current Opinion in 
Hematology. 2000;7:113-116. DOI: 
10.1097/00062752-200003000-00007
[140] Samaja M, Rubinacci A, 
Motterlini R, De PA, Portinaro 
N. Red cell aging and active 
calcium transport. Experimental 
Gerontology. 1990;25:279-286. DOI: 
10.1016/0531-5565(90)90063-8
[141] Barodka V, Mohanty JG, Mustafa 
AK, Santhanam L, Nyhan A, Bhunia 
AK. Nitroprusside inhibits calcium-
induced impairment of red blood 
cell deformability. Transfusion. 
2013;54:434-444. DOI: 10.1111/trf.12291
[142] Jakeman GN, Saul A, Hogarth WL, 
Collins WE. Anaemia of acute malaria 
infections in non-immune patients 
primarily results from destruction of 
uninfected erythrocytes. Parasitology. 
1999;119:127-133
[143] Weiss L. The red pulp of the spleen: 
Structural basis of blood flow. Clinics in 
Haematology. 1983;12:375-393
[144] Wang S, Dale GL, Song P, Viollet B, 
Zou MH. AMPKalpha1 deletion shortens 
erythrocyte life span in mice: Role of 
oxidative stress. The Journal of Biological 




[145] Mavondo GA, Mzingwane 
MML. Parasitic causes of hemolytic 
anemia: Severe malaria anemia 
pathophysiology, current and 
experiemental phytotherapeutics in 
malaria anemia. In: Khan J, editor. 
Current Topics on Anaemia. Rijeka, 
Croatia-EU: Intechopen; 2017
[146] Miller LH, Ackerman HC, X-z 
S, Wellems TE. Malaria biology and 
disease pathogenesis: Insights for 
new treatments. Nature Medicine. 
2013;19(2):156-167
[147] Guzman NJ, Fang MZ, Tang SS, 
Ingelfinger JR, Garg LC. Autocrine 
inhibition of Na+/K+-ATPase by nitric 
oxide in mouse proximal tubule 
epithelial cells. The Journal of Clinical 
Investigation. 1995;95:2083-2088
[148] Roczniak A, Burns KD. Nitric 
oxide stimulates guanylate cyclase and 
regulates sodium transport in rabbit 
proximal tubule. The American Journal 
of Physiology. 1996;270:F106-F115
[149] Wambach G, Overhoff U, 
Hossmann V. Sodium transport and 
red cell deformability. Klinische 
Wochenschrift. 1985;3(Suppl. 3):35-37
[150] Rohn TT, Hinds TR, Vincenzi FF. 
Inhibition of Ca2+-pump ATPase and the 
Na+/K+-pump ATPase by iron-generated 
free radicals. Protection by 6,7-dimethyl-
2,4-DI-1-pyrrolidinyl-7H-pyrrolo[2,3-d] 
pyrimidine sulfate (U-89843D), a 
potent, novel, antioxidant/free radical 
scavenger. Biochemical Pharmacology. 
1996;51:471-476
[151] Rohn TT, Hinds TR, Vincenzi 
FF. Ion transport ATPases as targets for 
free radical damage. Protection by an 
aminosteroid of the Ca2+ pump ATPase 
and Na+/K+ pump ATPase of human 
red blood cell membranes. Biochemical 
Pharmacology. 1993;46:525-534
[152] Clark IA, Cowden WB. The 
pathophysiology of falciparum malaria. 
Pharmacology & Therapeutics. 
2003;99:221-260
[153] Zhang X, Wu J, Dou Y, Xia B, 
Rong W, Rimbach G, et al. Asiatic 
acid protects primary neurons against 
C-ceramide-induced apoptosis. 
European Journal of Pharmacology. 
2012;679:51-59
[154] Asamoah KA, Robb DA, Furman 
BL. Chronic chloroquine treatment 
enhances insulin release in rats. 
Diabetes Research and Clinical Practice. 
1990;9:273-278
[155] Phillips RE. Hypoglycaemia is an 
important complication of falciparum 
malaria. The Quarterly Journal of 
Medicine. 1989;71:477-483
[156] Mehta M, Sonawat HM, 
Sharma S. Malaria parasite-infected 
erythrocytes inhibit glucose utilization 
in uninfected red cells. FEBS Letters. 
2005;579(27):6151-6158
[157] Krishna S, Waller DW, Terkuile 
F, Kwiatkowski D, Crawley J, 
Craddock CFC, et al. Lactic acidosis 
and hypoglycaemia in children with 
severe malaria-pathophysiological 
and prognostic significance. 
Transactions of the Royal Society 
of Tropical Medicine and Hygiene. 
1994;88:67-73
[158] Warrell DA, Veall N, 
Chanthanavich P, Karbwang J, White 
NJ, Looareesuwan S, et al. Cerebral 
anaerobic glycolysis and reduced 
cerebral oxygen transport in human 
malaria. Lancet. 1988;ii:534-538
[159] English M, Sauerwein R, Waruiru 
C, Mosobo M, Obiero J, Lowe B, et al. 
Acidosis in severe childhood malaria. 
The Quarterly Journal of Medicine. 
1997;90:263-270
[160] Melillo G, Musso T, Sica A, Taylor 
LS, Cox GW, Varesio L. A hypoxia-
responsive element mediates a novel 
29
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
pathway of activation of the inducible 
nitric oxide synthase promoter. The 
Journal of Experimental Medicine. 
1995;182:1683-1693
[161] Baker RG, Hayden MS. NF-kB, 
infammation, and metabolic disease. 
Cell Metabolism. 2011;15:11-22
[162] Kettelhut I, Fiers W, Goldberg 
AL. The toxic effects of tumor necrosis 
factor in vivo and their prevention by 
cyclooxygenase inhibitors. Proceedings 
of the National Academy of Sciences 
of the United States of America. 
1987;84:4273-4277
[163] Tracey KJ, Beutler B, Lowry SF, 
Merryweather J, Wolpe S, Milsark IW, 
et al. Shock and tissue injury induced by 
recombinant human cachectin. Science. 
1986;234:470-474
[164] Grau GE, Fajardo LF, Piquet P-F, 
Allet B, Lambert P-H. Tumor necrosis 
factor (cachectin) as an essential 
mediator in murine cerebral malaria. 
Science. 1987;237:1210-1212
[165] Coxon RE, Fekade D, Knox K, 
Hussein K, Melka A. The efect of 
antibody against TNF alpha on cytokine 
response in Jarisch-Herxheimer 
reactions of louse-borne relapsing fever. 
The Quarterly Journal of Medicine. 
1997;90:213-221
[166] Jesus JA, Lago JHG, Laurenti 
MD, Yamamoto ES, Passero 
LFD. Antimicrobial activity of 
oleanolic and ursolic acids: An update. 
Evidence-based Complementary and 
Alternative Medicine. 2015;2015:14. 
DOI: 10.1155/2015/620472
[167] Wen X, Sun H, Liu J, Cheng K, 
Zhang P, Zhang L, et al. Naturally 
occurring pentacyclic triterpenes as 
inhibitors of glycogen phosphorylase: 
Synthesis, structure-activity 
relationships, and X-ray crystallographic 
studies. Journal of Medicinal Chemistry. 
2008;51:3540-3554
[168] Potz BA, Scrimgeour LA, Sabe 
SA, Clements RT, Sodha NR, Sellke 
FW. Glycogen synthase kinase 3β 
inhibition reduces mitochondrial 
oxidative stress in chronic myocardial 
ischemia. Journal of Thoracic 
and Cardiovascular Surgery. 
2018;155(6):2492-2503. DOI: 10.1016/j.
jtcvs.2017.12.127
[169] Elbadawi NEE, Mohamed MI, 
Dawod OY, Ali KE, Daoud OH, Ali 
EM, et al. Effect of quinine therapy 
on plasma glucose and plasma 
insulin levels in pregnant women 
infected with Plasmodium falciparum 
malaria in Gezira state. Eastern 
Mediterranean Health Journal. 
2011;17:697-700
[170] Musabayane CT, Murambirwa P, 
Joosab N, Masola B, Mukaratirwa S. The 
effects of chloroquine on blood glucose 
and plasma insulin concentrations in 
male Sprague Dawley rats. Endocrine 
Abstracts. 2010;21:139
[171] Acquah S, Boampong JN, Eghan 
Jnr BA, Eriksson M. Evidence of insulin 
resistance in adult uncomplicated 
malaria: Result of a 2-year prospective 
study. Malaria Research and 
Treatment. 2014;2014:136148. DOI: 
10.1155/2014/136148
[172] Ramachandran V, Saravanan 
R. Efcacy of asiatic acid, a pentacyclic 
triterpene on attenuating the key 
enzymes activities of carbohydrate 
metabolism in streptozotoc ininduced 
diabetic rats. Phytomedicine. 
2013;20:230-236
[173] Schulman JL, Carleton JL, Whitney 
G, Whitehorn JC. Effect of glucagon 
on food intake and body weight in 
man. Journal of Applied Physiology. 
1957;11:419-421
[174] Dabadghao VS, Singh VB, Sharma 
D, Meena BL. A study of serum lactate 
level in malaria and its correlation with 
severity of disease. International Journal 
Malaria
30
of Advanced Medical and Health 
Research. 2015;2:28-32
[175] Barsoum RS. Malarial aute renal 
failure. Journal of the American Society 
of Nephrology. 2000;11:2147-2154
[176] Dondorp AM, Day NP. The 
treatment of severe malaria. 
Transactions of the Royal Society 
of Tropical Medicine and Hygiene. 
2007;101(7):633-634
[177] Thanachartwet V, Desakorn 
V, Sahassananda D, Win KKYK, 
Supaporn T. Acute renal failure 
in patients with severe falciparum 
malaria: Using the WHO 2006 and 
RIFLE criteria. International Journal 
of Nephrology. 2013;2013:6. DOI: 
10.1155/2013/841518
[178] Raffray L, Receveur M-C, 
Beguet M, Lauroua P, Pistone T, 
Malvy D. Severe delayed autoimmune 
haemolytic anaemia following 
artesunate administration in severe 
malaria: A case report. Malaria 
Journal. 2014;13:398. Available from: 
http://www.malariajournal.com/
content/13/1/398
[179] Percário S, Moreira DR, Gomes 
BAQ , Ferreira MES, Gonçalves ACM, 
Laurindo PSO, et al. Oxidative stress 
in malaria. International Journal of 
Molecular Sciences. 2012;13(12): 
16346-16372. DOI: 10.3390/
ijms131216346
[180] Maitland K, Pamba A, Fegan G, 
Njuguna P, Nadel S, Newton CRJC, et al. 
Perturbations in electrolyte levels in 
Kenyan children with severe malaria 
complicated by acidosis. Clinical 
Infectious Diseases. 2005;40(1):9-16. 
DOI: 10.1086/426022
[181] Hanson J, Hossain A, 
Charunwatthana P, Hassan MU, Davis 
TME, Lam SWK, et al. Hyponatremia 
in severe malaria: Evidence for an 
appropriate anti-diuretic hormone 
response to hypovolemia. The American 
Journal of Tropical Medicine and 
Hygiene. 2009;80(1):141-145
[182] Musabayane CT, Munjeri O, 
Matavire TP. Transdermal delivery 
of chloroquine by amidated pectin 
hydrogel matrix patch in the rat. Renal 
Failure. 2003;25(4):525-534
[183] Giovanella F, Ferreira GK, 
de Prá SDT, Carvalho-Silva M, 
Gomes LM, Scaini G, et al. Effects 
of primaquine and chloroquine on 
oxidative stress parameters in rats. 
Annals of the Brazilian Academy of 
Sciences. 2015;87(2):1487-1496. DOI: 
10.1590/0001-3765201520140637
[184] Patel H, Dhangar K, Sonawane Y, 
Surana S, Karpoormath R, Thapliyal N, 
et al. In search of selective 11b-HSD type 
1 inhibitors without nephrotoxicity: 
An approach to resolve the metabolic 
syndrome by virtual based screening. 
Arabian Journal of Chemistry. 
2018;11:221-232. DOI: 10.1016/j.
arabjc.2015.08.003
[185] Stewart PM, Worwood CB, Walker 
BR. Steroid hormones and hypertension: 
The cortisol-cortisone shuttle. Steroids. 
1993;58:614-620
[186] Walker BR, Connacher AA, 
Lindsay RM, Webb DJ, Edwards 
CRW. Carbenoxolone increases hepatic 
insulin sensitivity in man: A novel 
role for 11-oxosteroid reductase in 
enhancing glucocorticoid receptor 
activation. The Journal of Clinical 
Endocrinology and Metabolism. 
1995;80:3155-3159
[187] Kotelevtsev Y, Brown R, Fleming 
WS, Kenyon C, Edwards CRW, Seckl 
JR, et al. Hypertension inmice lacking 
11b hydroxysteroid dehydrogenase type 
2. The Journal of Clinical Investigation. 
1999;103:683-689
[188] Park SB, Park JS, Jung WH, 
Kim HK, Kwak HJ, Ahn JH, et al. 
31
Malarial Pathophysiology and Phytochemical Interventions: A Current Discourse on Oxidative…
DOI: http://dx.doi.org/10.5772/intechopen.83529
Anti-inflammatory effect of a selective 
11b-hydroxysteroid dehydrogenase type 
1 inhibitor via the stimulation of heme 
oxygenase-1 in LPS-activated mice and 
J774.1 murine macrophages. Journal of 
Pharmacological Sciences. 2016;131: 
241-250. DOI: 10.1016/j.jphs.2016.07.003
[189] Puigoriol-Illamola D, Griñán-Ferré 
C, Vasilopoulou F, Leiva R, Vázquez 
S, Pallàs M. 11β-HSD1 inhibition by 
RL-118 promotes autophagy and 
correlates with reduced oxidative 
stress and inflammation, enhancing 
cognitive performance in SAMP8 
mouse model. Molecular Neurobiology. 
2018;55(12):8904-8915. DOI: 10.1007/
s12035-018-1026-8
